Patrys Limited

ASX:PAB ISIN:AU000000PAB9

Patrys Limited (ASX:PAB) is an Australia-based company. The principal activity of the Company is to develop natural human antibody based therapeutic products for the treatment of cancer and other diseases. 
 
    

查看其它語言版本

新聞

2010年8月2日澳洲股市

🕔8/2/2010 1:30:45 PM 10777

本週澳洲股市未受華爾街平淡帶動的影響,開盤略漲。早盤時,黃金類和金融類股票揚升。基準指數S&P/ASX200 上揚15.2點至4508.7點,綜合指數上揚14 點至4521.4點。

閱讀全文
###

32,543 公司背景瀏覽

  • 本頁瀏覽人次: (過去7日: 16) (過去30日: 55) (自發布以來: 6465) 

公司詳細

    主要部門
  • 醫療-製藥 
  • 支柱產業
  • None 

更多新聞紀錄

  • 2024/11/22: Chair's Address and CEO Presentation to 2024 AGM*
  • 2024/10/30: Appendix 4C - Quarterly - 30 September 2024*
  • 2024/10/21: Notice of Annual General Meeting/Proxy Form*
  • 2024/10/14: Notification of cessation of securities - PAB*
  • 2024/10/02: PAT-DX1 clinical development update*
  • 2024/09/20: PAT-DX1 GMP specification testing update*
  • 2024/08/29: PAT-DX1 GMP specification testing update*
  • 2024/08/23: Appendix 4G and Corporate Governance Statement*
  • 2024/08/23: Appendix 4E and 2024 Annual Report*
  • 2024/07/29: Further update on PAT-DX1 GMP manufacturing run*
*refer to company website